Geode Capital Management’s KALA BIO KALA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$45.2K Buy
5,221
+3,998
+327% +$84.5K ﹤0.01% 4339
2025
Q4
$34K Sell
1,223
-135
-10% -$6.04K ﹤0.01% 4307
2025
Q3
$104K Buy
1,358
+231
+20% +$115K ﹤0.01% 4122
2025
Q2
$268K Buy
1,127
+30
+3% +$5.85K ﹤0.01% 3775
2025
Q1
$314K Buy
1,097
+144
+15% +$54.5K ﹤0.01% 3706
2024
Q4
$331K Buy
953
+211
+28% +$66.5K ﹤0.01% 3732
2024
Q3
$212K Buy
742
+364
+96% +$115K ﹤0.01% 3880
2024
Q2
$134K Buy
378
+15
+4% +$4.96K ﹤0.01% 4048
2024
Q1
$142K Sell
363
-6
-2% -$2.23K ﹤0.01% 4041
2023
Q4
$129K Hold
369
﹤0.01% 4096
2023
Q3
$164K Buy
369
+14
+4% +$9.19K ﹤0.01% 4056
2023
Q2
$259K Buy
+355
New +$276K ﹤0.01% 3920
2023
Q1
Sell
-179
Closed -$340K 4818
2022
Q4
$340K Hold
179
﹤0.01% 3842
2022
Q3
$99K Hold
179
﹤0.01% 4582
2022
Q2
$134K Sell
179
-203
-53% -$319K ﹤0.01% 4458
2022
Q1
$1.32M Buy
382
+56
+17% +$147K ﹤0.01% 3484
2021
Q4
$985K Sell
326
-48
-13% -$223K ﹤0.01% 3732
2021
Q3
$2.44M Buy
374
+72
+24% +$621K ﹤0.01% 3264
2021
Q2
$3.99M Buy
302
+29
+11% +$456K ﹤0.01% 3037
2021
Q1
$4.6M Buy
273
+32
+13% +$625K ﹤0.01% 2829
2020
Q4
$4.08M Buy
241
+8
+3% +$151K ﹤0.01% 2706
2020
Q3
$4.37M Sell
233
-19
-8% -$437K ﹤0.01% 2474
2020
Q2
$6.62M Buy
252
+114
+83% +$3.23M ﹤0.01% 2174
2020
Q1
$3.03M Buy
138
+3
+2% +$47.9K ﹤0.01% 2437
2019
Q4
$1.25M Buy
135
+13
+11% +$126K ﹤0.01% 3201
2019
Q3
$1.16M Hold
122
﹤0.01% 3176
2019
Q2
$1.95M Buy
122
+19
+18% +$315K ﹤0.01% 2971
2019
Q1
$2.13M Buy
103
+23
+29% +$409K ﹤0.01% 2815
2018
Q4
$977K Buy
80
+35
+78% +$607K ﹤0.01% 3125
2018
Q3
$1.1M Buy
45
+8
+22% +$244K ﹤0.01% 3181
2018
Q2
$1.27M Buy
37
+3
+9% +$115K ﹤0.01% 3086
2018
Q1
$1.34M Buy
34
+6
+21% +$228K ﹤0.01% 2985
2017
Q4
$1.27M Buy
28
+2
+8% +$93.6K ﹤0.01% 3001
2017
Q3
$1.5M Buy
+26
New +$1.43M ﹤0.01% 2913

Other funds holding KALA

Geode Capital Management's KALA Position: Q1 2026 in Review

Geode Capital Management increased its KALA BIO (KALA) stake by 327% in Q1 2026, buying an estimated $84.5K and bringing the position to 5,221 shares worth $45.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4339.

Geode Capital Management first reported a position in KALA in Q3 2017 and has held it in 34 quarters since. The position peaked at $6.62M in Q2 2020. 28 funds tracked by Wall St. Rank hold KALA as of Q1 2026.

  • Geode Capital Management held 5,221 shares of KALA BIO worth $45.2K as of Q1 2026.
  • Geode Capital Management bought 3,998 KALA BIO shares in Q1 2026, an estimated $84.5K.
  • KALA BIO made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #4339 holding.
  • Geode Capital Management first reported a position in KALA BIO in Q3 2017 and has held it in 34 quarters since.
  • Geode Capital Management's KALA BIO position peaked at $6.62M in Q2 2020.
  • 28 funds tracked by Wall St. Rank held KALA BIO as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.